Enhancer architecture sensitizes cell specific responses to <i>Notch</i> gene dose via a bind and discard mechanism.

Kuang, Yi; Golan, Ohad; Preusse, Kristina; Cain, Brittany; Christensen, Collin J; Salomone, Joseph; Campbell, Ian; Okwubido-Williams, FearGod V et al. · Elife · 2020

basic_science · Level V

Where this comes from

Abstract

Notch pathway haploinsufficiency can cause severe developmental syndromes with highly variable penetrance. Currently, we have a limited mechanistic understanding of phenotype variability due to gene dosage. Here, we unexpectedly found that inserting an enhancer containing pioneer transcription factor sites coupled to Notch dimer sites can induce a subset of <i>Notch</i> haploinsufficiency phenotypes in <i>Drosophila</i> with wild type <i>Notch</i> gene dose. Using <i>Drosophila</i> genetics, we show that this enhancer induces Notch phenotypes in a Cdk8-dependent, transcription-independent manner. We further combined mathematical modeling with quantitative trait and expression analysis to build a model that describes how changes in Notch signal production versus degradation differentially impact cellular outcomes that require long versus short signal duration. Altogether, these findings support a 'bind and discard' mechanism in which enhancers with specific binding sites promote rapid Cdk8-dependent Notch turnover, and thereby reduce Notch-dependent transcription at other loci and sensitize tissues to gene dose based upon signal duration.

Medical subject headings